🇺🇸 FDA

Intelligence · Clinical Pipeline

Rhythm Pharmaceuticals Netherlands Pipeline

All ClinicalTrials.gov programs at Rhythm Pharmaceuticals Netherlands — phase, modality, and trial IDs.

Programs
35

Quick answer

Rhythm Pharmaceuticals Netherlands has 35 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other terminated

    1 trial

  2. Access Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  3. Anti-Arrhythmics

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmia, Cardiac

    approved small molecule terminated

    1 trial

  4. Arctic Front Advance Cardiac CryoAblation system

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial

  5. CG Future Annuloplasty Ring/Band

    Rhythm Pharmaceuticals Netherlands B.V.

    Mitral Valve Insufficiency

    approved other completed

    1 trial

  6. CRT

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  7. CRT + AOP

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  8. CRT-P or CRT-D Device

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure, Congestive

    approved other terminated

    1 trial

  9. CareLink Remote Monitoring

    Rhythm Pharmaceuticals Netherlands B.V.

    Pacemaker

    approved other completed

    1 trial

  10. Conducted AF-Response Algorithm (CAFR) On

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial

  11. DOAC

    Rhythm Pharmaceuticals Netherlands B.V.

    Ventricular Tachycardia

    approved small molecule completed

    1 trial

  12. Dual chamber pacemeker

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  13. Fill out Questionnaire

    Rhythm Pharmaceuticals Netherlands B.V.

    Bradycardia

    approved other completed

    1 trial

  14. Freezor® Cardiac Cryoablation Catheter CryoConsole System

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Atrioventricular Nodal Reentry

    approved other completed

    1 trial

  15. ICD Ablation plus VT-ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    1 trial

  16. Implantable Cardiac Defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Ventricular

    approved other completed

    2 trials

  17. Implantable Cardiac Monitor

    Rhythm Pharmaceuticals Netherlands B.V.

    Chagas Disease

    approved other terminated

    1 trial

  18. Implantable Defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Disease

    approved other completed

    1 trial

  19. Implantable cardioverter defibrillator

    Rhythm Pharmaceuticals Netherlands B.V.

    Acute Myocardial Infarction

    approved other completed

    1 trial

  20. Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmias, Cardiac

    approved small molecule active

    1 trial

  21. LV dp/dt pressure measurement

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  22. Managed Ventricular Pacing programmed ON/OFF

    Rhythm Pharmaceuticals Netherlands B.V.

    Cardiovascular Diseases

    approved other completed

    1 trial

  23. Medtronic AT500

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  24. Medtronic Endeavor Resolute

    Rhythm Pharmaceuticals Netherlands B.V.

    Coronary Artery Disease

    approved other completed

    1 trial

  25. Monthly Review Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  26. Pacemaker Medtronic EnRhythm

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  27. Programming (CRT-D, ICD OptiVol® and Cardiac Compass® )

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial

  28. RF Ablation procedure

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial

  29. Reveal® XT Insertable Cardiac Monitor

    Rhythm Pharmaceuticals Netherlands B.V.

    Cryptogenic Symptomatic Transient Ischemic Attack

    approved other completed

    1 trial

  30. Search AV+ algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmia, Sinus

    approved other terminated

    1 trial

  31. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Healthy

    approved small molecule completed

    1 trial

  32. Stent

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Disease

    approved other completed

    1 trial

  33. TYRX™ Absorbable Antibacterial Envelope

    Rhythm Pharmaceuticals Netherlands B.V.

    CIED Related Infection

    approved other completed

    1 trial

  34. Use of an Implantable Loop Recorder

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  35. early standardised rhythm control

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

Frequently asked questions

How many pipeline programs does Rhythm Pharmaceuticals Netherlands have?

35 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.